Dr. Rouce is a pediatric oncologist and physician scientist whose clinical research focuses on difficult-to-treat blood cancers, specifically how to harness the immune system to attack them. She has spent the past 12 years in the Center for Cell and Gene Therapy at Texas Children’s Hospital leading a research program translating genetically engineered immune cells to first-in-human immunotherapy trials. She has significant experience in every aspect of clinical trial development and in addition to serving as principal investigator on CAR-T trials for blood cancers, has served as Project Leader for projects for the NIH Lymphoma SPORE, LLS Specialized Center of Research, and Stand Up to Cancer. She leads health equity and disparities initiatives locally and nationally and is dedicated to addressing access barriers to novel cancer clinical trials for children, adolescents/young adults, underrepresented minorities, patients with limited resources and those with geographic constraints.